Related references
Note: Only part of the references are listed.Molecular interaction of α-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells
R. M. Zhou et al.
MOLECULAR BIOLOGY REPORTS (2010)
Molecular mechanisms of α-synuclein neurodegeneration
Elisa A. Waxman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro
Dong Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation
Golam Sadik et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The Parkinson disease-associated A30P mutation stabilizes α-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells
Wei Song et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Activated Actin-Depolymerizing Factor/Cofilin Sequesters Phosphorylated Microtubule-Associated Protein during the Assembly of Alzheimer-Like Neuritic Cytoskeletal Striations
Ineka T. Whiteman et al.
JOURNAL OF NEUROSCIENCE (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
Kurt R. Brunden et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Controlling the mass action of alpha-synuclein in Parkinson's disease
Changyoun Kim et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat
Won-Seok Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease
An Goris et al.
ANNALS OF NEUROLOGY (2007)
Alpha-Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Tetyana Duka et al.
FASEB JOURNAL (2006)
Untangling the tau gene association with neurodegenerative disorders
Alan M. Pittman et al.
HUMAN MOLECULAR GENETICS (2006)
Expanding insights of mitochondrial dysfunction in Parkinson's disease
PM Abou-Sleiman et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Parkinson's disease α-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death
LJ Martin et al.
JOURNAL OF NEUROSCIENCE (2006)
Selective vulnerability of dopaminergic neurons to microtubule depolymerization
Y Ren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor
G Cappelletti et al.
FEBS LETTERS (2005)
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease
AJ Myers et al.
HUMAN MOLECULAR GENETICS (2005)
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress
RH Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
M Frasier et al.
EXPERIMENTAL NEUROLOGY (2005)
The MPTP model of Parkinson's disease
RJ Smeyne et al.
MOLECULAR BRAIN RESEARCH (2005)
PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila
I Nishimura et al.
CELL (2004)
Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration
RE Drolet et al.
NEUROTOXICOLOGY (2004)
Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation
PT Kotzbauer et al.
EXPERIMENTAL NEUROLOGY (2004)
Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy
BI Giasson et al.
ACTA NEUROPATHOLOGICA (2003)
Role of α-synuclein carboxy-terminus on fibril formation in vitro
IVJ Murray et al.
BIOCHEMISTRY (2003)
Initiation and synergistic fibrillization of tau and alpha-synuclein
BI Giasson et al.
SCIENCE (2003)
Colocalization of tau and alpha-synuclein epitopes in Lewy bodies
T Ishizawa et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
The mouse MPTP model: gene expression changes in dopaminergic neurons
K Kuhn et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
W Dauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Concurrence of α-synuclein and tau brain pathology in the Contursi kindred
JE Duda et al.
ACTA NEUROPATHOLOGICA (2002)
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
MK Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Dopamine-dependent neurotoxicity of α-synuclein:: A mechanism for selective neurodegeneration in Parkinson disease
J Xu et al.
NATURE MEDICINE (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Glycogen synthase kinase-3,β is complexed with tau protein in brain microtubules
W Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tubulin seeds α-synuclein fibril formation
MA Alim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry:: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3β
CH Reynolds et al.
JOURNAL OF NEUROCHEMISTRY (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
α-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP
M Vila et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
